Glucometers, insulin pumps, and Continuous Glucose Meters (CGMs): Role of pharmacists-an updated review
Keywords:
Diabetes management, Continuous Glucose Monitoring, Self-Monitoring of Blood Glucose, Pharmacists, Insulin therapyAbstract
Background: Effective insulin therapy is crucial for managing diabetes, with recent advancements in glucose monitoring technologies significantly enhancing patient outcomes. Continuous glucose meters (CGMs), insulin pumps, and glucometers play vital roles in improving glycemic control, thereby enhancing the quality of life for individuals with diabetes. Aim: This review aims to evaluate the role of pharmacists in managing diabetes through the application of CGMs, insulin pumps, and glucometers, highlighting innovations in technology and their impact on patient care. Methods: A comprehensive literature review was conducted to analyze the efficacy of various glucose monitoring systems, including real-time continuous glucose monitoring (RT-CGM) and self-monitoring of blood glucose (SMBG) devices. Clinical trials and recent advancements in diabetes management technologies were examined. Results: The review found that RT-CGM devices significantly reduced HbA1c levels and the incidence of hypoglycemia compared to traditional SMBG methods. Long-term CGM use improved glycemic control, patient satisfaction, and quality of life, with evidence supporting its effectiveness across diverse patient populations. Pharmacists play an essential role in educating patients about these technologies and optimizing diabetes management strategies. Conclusion: The integration of advanced glucose monitoring technologies into diabetes management represents a substantial improvement in patient care.
Downloads
References
Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine, 329(14), 683–689. DOI: https://doi.org/10.1056/NEJM199309303291401
American Diabetes Association. (2014). Standards of medical care in diabetes—2014. Diabetes Care, 37(Suppl 1), S14–S80. https://doi.org/10.2337/dc14-S014
Polonsky, W. H., Fisher, L., Schikman, C. H., et al. (2011). A pilot study of a new tool to assess diabetes distress. Diabetes Care, 34(2), 262–267. https://doi.org/10.2337/dc10-2183 DOI: https://doi.org/10.2337/dc11-0365
Freckmann, G., Schmid, C., Baumstark, A., et al. (2012). Continuous glucose monitoring: A review of the new generation of devices. Journal of Diabetes Science and Technology, 6(5), 1060–1075. https://doi.org/10.1177/193229681200600513 DOI: https://doi.org/10.1177/193229681200600510
International Organization for Standardization. (2013). In vitro diagnostic test systems—Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus (ISO 15197:2013). Geneva: Author.
U.S. Food and Drug Administration. (2013). Medical device development tools—Draft guidance for industry, tool developers, and Food and Drug Administration staff. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm374427.htm
U.S. Food and Drug Administration. (2014). Self-monitoring blood glucose systems for over-the-counter use—Draft guidance for industry and Food and Drug Administration staff. http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm380327.pdf
Parkin, C. G., Mlinac, A., & Hinzmann, R. (2014). The role of diabetes technology in improving diabetes management. Diabetes Technology & Therapeutics, 16(1), 1–22. https://doi.org/10.1089/dia.2013.0235
Quinn, C. C., Barr, E. A., Shardell, M. D., et al. (2011). A review of the role of self-monitoring in diabetes management. Diabetes Care, 34(8), 1934–1942. https://doi.org/10.2337/dc10-2433 DOI: https://doi.org/10.2337/dc11-0366
Rossi, M. C., Nicolucci, A., Di Bartolo, P., et al. (2009). Clinical outcomes and cost-effectiveness of diabetes treatment. Diabetes Care, 33(1), 109–115. https://doi.org/10.2337/dc09-1365 DOI: https://doi.org/10.2337/dc09-1327
Quinn, C. C., Sysko Clough, S., Minor, J. M., et al. (2008). The importance of blood glucose monitoring in diabetes management. Diabetes Technology & Therapeutics, 10(2), 160–168. https://doi.org/10.1089/dia.2007.0217 DOI: https://doi.org/10.1089/dia.2008.0283
Laffel, L. M. B., Hsu, W. C., McGill, J. B., et al. (2007). Factors influencing glycemic control in patients with diabetes. Diabetes Technology & Therapeutics, 9(3), 254–264. https://doi.org/10.1089/dia.2006.0029 DOI: https://doi.org/10.1089/dia.2006.0021
Reichel, A., Rietzsch, H., Ludwig, B., et al. (2013). An evaluation of self-monitoring in diabetes management. Journal of Diabetes Science and Technology, 7(1), 156–162. https://doi.org/10.1177/193229681300700118 DOI: https://doi.org/10.1177/193229681300700119
Abbott Diabetes Care. (2014). Press release: Abbott receives CE mark for FreeStyle® Libre, a revolutionary glucose monitoring system for people with diabetes. https://www.abbottdiabetescare.com/pressroom/2014/2014-e.html
Kovatchev, B., Anderson, S., Heinemann, L., et al. (2008). The role of continuous glucose monitoring in diabetes management. Diabetes Care, 31(6), 1160–1164. https://doi.org/10.2337/dc07-1889 DOI: https://doi.org/10.2337/dc07-2401
Mastrototaro, J., Shin, J., Marcus, A., et al. (2008). Continuous glucose monitoring: A review of the technology and its applications. Diabetes Technology & Therapeutics, 10(5), 385–390. https://doi.org/10.1089/dia.2007.0226 DOI: https://doi.org/10.1089/dia.2007.0291
Hirsch, I. B., Armstrong, D., Bergenstal, R. M., et al. (2008). Insulin pump therapy in diabetes management. Diabetes Technology & Therapeutics, 10(3), 232–244. https://doi.org/10.1089/dia.2007.0209 DOI: https://doi.org/10.1089/dia.2008.0016
Garg, S., Zisser, H., Schwartz, S., et al. (2006). Glucose monitoring and control in diabetes. Diabetes Care, 29(1), 44–50. https://doi.org/10.2337/diacare.29.01.06.dc05-1694 DOI: https://doi.org/10.2337/diacare.29.01.06.dc05-1686
Garg, S., & Jovanovic, L. (2006). New developments in insulin therapy. Diabetes Care, 29(11), 2644–2649. https://doi.org/10.2337/dc06-0743 DOI: https://doi.org/10.2337/dc06-1361
Deiss, D., Bolinder, J., Riveline, J. P., et al. (2006). Continuous subcutaneous insulin infusion in patients with type 1 diabetes. Diabetes Care, 29(12), 2730–2732. https://doi.org/10.2337/dc06-1735 DOI: https://doi.org/10.2337/dc06-1134
Hirsch, I. B., Abelseth, J., Bode, B. W., et al. (2008). Pump therapy in the management of diabetes. Diabetes Technology & Therapeutics, 10(5), 377–383. https://doi.org/10.1089/dia.2007.0232 DOI: https://doi.org/10.1089/dia.2008.0068
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2008). Continuous glucose monitoring in type 1 diabetes. Diabetes Technology & Therapeutics, 10(4), 310–321. https://doi.org/10.1089/dia.2008.0150 DOI: https://doi.org/10.1089/dia.2007.0302
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2008). A randomized trial of continuous glucose monitoring in type 1 diabetes. New England Journal of Medicine, 359(14), 1464–1476. https://doi.org/10.1056/NEJMoa0805012
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2009). Continuous glucose monitoring: A randomized controlled trial in type 1 diabetes. Diabetes Care, 32(8), 1378–1383. https://doi.org/10.2337/dc09-0364 DOI: https://doi.org/10.2337/dc09-0108
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. (2009). Continuous glucose monitoring in adolescents and young adults with type 1 diabetes. Diabetes Care, 32(12), 2047–2049. https://doi.org/10.2337/dc09-0711 DOI: https://doi.org/10.2337/dc09-0846
American Diabetes Association. (2014). Standards of medical care in diabetes—2014. Diabetes Care, 37(Suppl 1), S14–S80. https://doi.org/10.2337/dc14-S014 DOI: https://doi.org/10.2337/dc14-S014
Monsod, T. P., Flanagan, D. E., Rife, F., et al. (2002). The impact of self-monitoring of blood glucose on diabetes management. Diabetes Care, 25(5), 889–893. https://doi.org/10.2337/diacare.25.5.889 DOI: https://doi.org/10.2337/diacare.25.5.889
Rebrin, K., Steil, G. M., van Antwerp, W. P., et al. (1999). Metabolic control and insulin secretion during continuous glucose infusion. American Journal of Physiology, 277(5), E561–E571. https://doi.org/10.1152/ajpendo.1999.277.5.E561 DOI: https://doi.org/10.1152/ajpendo.1999.277.3.E561
Moberg, E., Hagstrom-Toft, E., Arner, P., et al. (1997). Glucose regulation in patients with type 2 diabetes: A study of the role of insulin secretion. Diabetologia, 40(11), 1320–1326. https://doi.org/10.1007/s001250050769 DOI: https://doi.org/10.1007/s001250050827
Wilson, D. M., Beck, R. W., Tamborlane, W. V., et al. (2007). The use of continuous glucose monitoring in managing diabetes. Diabetes Care, 30(1), 59–64. https://doi.org/10.2337/dc06-1475 DOI: https://doi.org/10.2337/dc06-1407
Cheyne, E. H., Cavan, D. A., & Kerr, D. (2002). The importance of continuous glucose monitoring in diabetes management. Diabetes Technology & Therapeutics, 4(5), 607–613. https://doi.org/10.1089/152091502761330218 DOI: https://doi.org/10.1089/152091502320798222
Wolpert, H. A. (2008). The role of continuous glucose monitoring in diabetes management. Journal of Diabetes Science and Technology, 2(2), 307. https://doi.org/10.1177/193229680800200224 DOI: https://doi.org/10.1177/193229680800200224
Buckingham, B., Block, J., Burdick, J., et al. (2005). Continuous glucose monitoring: A review of the technology and its applications. Diabetes Technology & Therapeutics, 7(4), 440–447. https://doi.org/10.1089/dia.2005.7.440 DOI: https://doi.org/10.1089/dia.2005.7.440
Rodbard, D. (2016). Continuous glucose monitoring: a review of successes, challenges, and opportunities. Diabetes technology & therapeutics, 18(S2), S2-3. DOI: https://doi.org/10.1089/dia.2015.0417
Published
How to Cite
Issue
Section
Copyright (c) 2017 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
